Coherus Oncology market cap CHRS
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Nov 2, 2026
- $115.8M
- Highest close in our data
- $1.6B
- Feb 2020
Coherus Oncology is worth $115.8M at the close on Nov 2, 2026, at $0.75 a share.
That is down 29% over the last year and down 91% over five years.
Its highest close in our data was $1.6B in Feb 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $115.8M | $115.8M | $296.8M | −28% |
| 2025 | $160.8M | $86.2M | $195.3M | −6% |
| 2024 | $171.7M | $83.3M | $319.6M | −54% |
| 2023 | $370.8M | $177.1M | $812.8M | −40% |
| 2022 | $616M | $487.8M | $1.1B | −50% |
| 2021 | $1.2B | $985.5M | $1.4B | −2% |
| 2020 | $1.3B | $977.4M | $1.6B | −2% |
| 2019 | $1.3B | $589.8M | $1.6B | +110% |
| 2018 | $607.5M | $547.6M | $1.4B | +19% |
| 2017 | $509.9M | $483.8M | $1.2B | −59% |
| 2016 | $1.2B | $515.7M | $1.3B | +38% |
| 2015 | $893M | $526.1M | $1.4B | +71% |
| 2014 | $521.5M | $424.4M | $521.5M | n/a |
Against its peers
Companies in Healthcare nearest Coherus Oncology's size, closest first, today.
| Company | Market cap |
|---|---|
| CHRSCoherus Oncology | $115.8M |
| KEQUKewaunee Scientific | $96.7M |
| ICCCImmucell | $95.9M |
| LFVNLifevantage | $73.5M |
| PDEXPro DEX | $184.5M |
| PLXProtalix BioTherapeutics | $206.3M |
| NATRNatures Sunshine Products | $211.5M |
| SPROSpero Therapeutics | $60.6M |
| ELMDElectromed | $223.9M |
| UTMDUtah Medical Products | $224.6M |
| APTAlpha Pro Tech | $56.3M |
| Peer median | $140.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Coherus Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.